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Vaccines and drugs have contributed to dramatic improvements in public health
worldwide. Over the last decade, there have been efforts in developing biomedical
ontologies that represent various areas associated with vaccines and drugs. These
ontologies combined with existing health and clinical terminology systems (e.g.,
SNOMED, RxNorm, NDF-RT, MedDRA, VO, OAE, and AERO) could play significant roles
on clinical and translational research. The first “Vaccine and Drug Ontology in the
Study of Mechanism and Effect” workshop (VDOSME 2012) provided a platform for
discussing problems and solutions in the development and application of
biomedical ontologies in representing and analyzing vaccines/drugs, vaccine/drug
administrations, vaccine/drug-induced immune responses (including positive host
responses and adverse events), and similar topics. The workshop covered two main
areas: (i) ontologies of vaccines, of drugs, and of studies thereof; and (ii) analysis of
administration, mechanism and effect in terms of representations based on such
ontologies. Six full-length papers included in this thematic issue focus on ontology
representation and time analysis of vaccine/drug administration and host responses
(including positive immune responses and adverse events), vaccine and drug adverse
event text mining, and ontology-based Semantic Web applications. The workshop,
together with the follow-up activities and personal meetings, provided a wonderful
platform for the researchers and scientists in the vaccine and drug communities to
demonstrate research progresses, share ideas, address questions, and promote
collaborations for better representation and analysis of vaccine and drug-related
terminologies and clinical and research data.Introduction and background
Innovative therapeutic interventions are critical to prevent and treat human and ani-
mal diseases. A way to broadly classify therapeutic interventions is through their tim-
ing in administration: Vaccines are classically administered to prevent the appearance
of a medical problem, while drugs are generally administered to treat a medical prob-
lem. Noticeable exceptions can be found for both classes of therapeutic interventions
such as cancer vaccines (that are administered after detection of the problem), and
protein pump inhibitors (that are often administered to prevent gastric problems in
co-therapy with other drugs or in specific hospital settings). Nevertheless, vaccines and
drugs are similarly regulated both in research and development, manufacturing, clinical© 2012 He et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
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monitoring. In a broader scope, vaccine is a special type of drug. Vaccines and drugs
also have many differences. For example, for vaccines, dose, time, route, and frequency
of administration are generally known quite precisely. However, since drugs are used
for patients with different conditions, dose, time, and frequency of drug administration
are often very difficult to establish. Since vaccines are often administered to healthy
people to prevent medical problems, attribution of an adverse event following vaccin-
ation is less likely to be confounded by signs or symptoms of underlying medical pro-
blems as it is with drugs that are administered to treat medical problems. However,
separation of manifestation of medical problem from manifestation of drug adverse
event is often very challenging. In the U.S.A, vaccines are regulated under different laws
by the Center for Biologics (CBER) at FDA, while drugs are regulated under the Food
Drug and Cosmetic Act by the Center for Drugs (CDER) at FDA. Safety surveillance
for vaccines is for the most part carried out by the Center for Disease Control (CDC)
in Atlanta, while for drugs it is carried out by the FDA. Due to these similarities and
differences between vaccines and drugs, a closer communication between these two
areas is important to create effective ontological frameworks around which we can
build comparative and predictive systems for both vaccines and drugs.
Although several related ontologies have been initiated with much progress made in
the recent years, we are still facing many challenges for fully and logically representing
vaccines and drugs and efficiently leveraging the ontologies. In the case of ontology
representation, no consensuses have been achieved on how to ontologically represent
many relevant areas, for example: (i) vaccine and drug administration dose, route, and
frequency, (ii) drug-drug interactions, drug-food interactions, and how they affect vac-
cine and drug adverse events, (iii) experimental testing and analysis of vaccine/drug-
induced immune responses, and (iv) the complexity of time constraints for clinical
events post vaccination or medication. Meanwhile, it is also a challenge to efficiently
apply biomedical ontologies to solve research and clinical problems. For example, is that
possible to apply ontologies for advanced literature mining in order to discover new gene
interaction networks underlying protective immunity or vaccine and drug adverse events?
How to apply ontologies for personalized medicine? How to use ontologies to improve
the performance of complex vaccine/drug research and clinical data analysis?
The full-day “Vaccine and Drug Ontology in the Study of Mechanism and Effect”
workshop (VDOSME 2012) aspires to become an international forum for researchers
to identify, propose, and discuss solutions for important research problems in ontology
representation and analysis of vaccine and drug formation and preparation, administra-
tion, function mechanisms, and induced host immune responses. The immune
responses can be positive responses for prevention and/or treatment of a disease, or
can be negative responses, i.e., adverse events. This workshop aimed to support the
deeper understanding of vaccine and drug mechanisms and effects.
VDOSME 2012 was held on July 21, 2012, at Graz, Germany. This workshop was
part of the third International Conference on Biomedical Ontology (ICBO 2012).
Detailed information about VDOSME 2012 is available on the web: http://kr-med.org/
icbofois2012/vdosme/. Fourteen people attended the workshop. The attendees included
paper presenters, senior academic and government scientists (e.g., Dr. Laszlo Balkanyi,
knowledge manager, European Centre for Disease Prevention and Control or ECDC),
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peer reviewing of each paper by at least three independent reviewers, six full-length
papers and one short-length papers were accepted for proceeding paper publications
and oral presentations in the workshop. One of the six papers came from the transfer
from another ICBO 2012 workshop ‘‘Methods for adverse events representation Ontology
and Information Model’’. Dr. Cui Tao, one oral presenter and co-organizer, presented her
talk from the USA through a teleconference system. After two additional rounds of inde-
pendent peer reviewing by the workshop co-organizers and the journal editors, the
selected six full-length papers were extended and accepted for publication in the current
issue of the Journal of Biomedical Semantics (JBMS).Summary of selected papers in the thematic issue
The six papers selected for this thematic issue are extended versions of the original full-
length papers presented at the VDOSME 2012 [1-6]. These papers cover a wide range of
topics including ontology modeling and analysis, ontology-based knowledge extraction
from big data case reports and literature, and ontology-based Semantic Web applications.
In the area of ontology modeling and representation, Lin and He introduce the onto-
logical classification and definitions of different vaccine components and vaccine admin-
istrations within the framework of the Vaccine Ontology (VO) [1]. Their studies show
that vaccine formulation and administration route can independently or collaboratively
affect the outcomes of vaccine-induced host responses. Tao et al. introduce a novel
method for using ontologies (including Time Event Ontology or TEO, VO, and Ontol-
ogy of Adverse Events or OAE) and semantic web technologies to represent and reason
temporal information and relations for post-vaccination events reported in the US FDA/
CDC Vaccine Adverse Event Reporting System (VAERS) [2]. Effective analyses of time
trends for post-vaccine adverse events (AEs) can enhance clinical research in different
areas such as vaccine safety analyses, causality assessments, and retrospective studies.
In the area of ontology-based text mining, Gurulingappa et al. outline an adaption of
a machine learning-based system for the identification and extraction of the relations
between drugs and adverse effects from MEDLINE case reports [3]. The authors used
an ontology-driven approach for the manual creation of the corpus used for bench-
marking, mapped the annotation ontology with the Ontology of Adverse Events (OAE),
and share a vision on OAE-driven information extraction. Using all PubMed abstracts
and the information in the VO, Hur et al. applied a genome-wide, centrality and
ontology-based literature mining approach to study fever and vaccination-associated
gene interaction networks [4]. This study identified a generic fever network consisting
more than 400 genes and a subset of the network (29 genes) associated with vaccines.
Detailed analysis of these gene networks allows new scientific discoveries and hypoth-
esis generations. After the publication of this work, Botsis et al. reported another vac-
cine adverse event text mining (VaeTM) system based on a semantic text mining
strategy, which has a sensitivity of 83.1% to detect symptoms, diagnoses, drugs, vac-
cines, and anatomical terms [7]. These works show how much the vaccine community
is leveraging upon text mining.
In ontology-based Semantic Web applications, Zhu et al. present a Semantic Web
technology framework to map the Structured Product Labeling (SPL) drug labels with
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meaningful use of SPL drug labels in clinical applications through standard NDF-RT
and RxNorm. In another paper, Doulaverakis et al. present a semantic enabled online
service called GalenOWL that offers real time drug-drug and drug-disease interaction
discovery [6]. A rule based inference method combining ontology information was
developed to provide drug recommendations. These OWL-based Semantic Web appli-
cations provide excellent use case studies on translating ontology research into possibly
very useful medical tool development.
Workshop presentations and discussions
In the workshop, the six full-length papers described above were orally presented. In
addition, Dr. Gully Burns also presented his short-paper on the development and usage
of “Ontology of Experimental Variables and Values” (OoEVV) for interlinking multiple
experimental variables that measure the same underlying quality but are expressed
using different measurement scales [8]. Furthermore, three general discussion sessions
were arranged and moderated by our workshop co-organizers. Dr. Luca Toldo moder-
ated a discussion session on the topic "Relation between drug and vaccine ontology in-
formatics". In this session, we discussed: (i) Similarities and differences between drug
and vaccine informatics, (ii) Collaborations between drug and vaccine ontology inform-
atics fields, and (iii) Collaborations between academia and industry. The second discus-
sion session was on the updates of the development of adverse event-related
ontologies. Melanie Courtot was invited to update the development of the Adverse
Event Reporting Ontology (AERO), and Dr. Yongqun He updated the development of
the OAE and its applications. The relation and coordination between AERO and OAE
were discussed. Dr. Gully Burns moderated the discussion session "Challenges and op-
portunities". We discussed current achievements and challenges and international com-
munity collaborations. The workshop attendees all agreed that such a workshop was
very beneficial to the community-based vaccine and drug-related ontology development
and applications. All attendees would like to welcome more VDOSME or similar work-
shops in the coming years. The VDOSME workshop, together with many activities
derived from the workshop, has provided an effective platform for the researchers in
the vaccine and drug communities to share research progresses and ideas, discuss pro-
blems and solutions, and promote interdisciplinary collaborations.
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